BCAT1 and glioma: Previous studies have shown that the branched-chain aminotransferase 1 and 2 (BCAT1 and BCAT2) enzymes, which catalyze the first step of BCAAs degradation, are overexpressed in gliomas [12], pancreatic cancer [13], and non-small-cell lung carcinoma [14].